Johnson Outdoors Inc
JOUT Nasdaq Sporting & Athletic Goods, Nec Financials FY2016βFY2025
What Johnson Outdoors Inc does
No business description yet.
- Legal name
- JOHNSON OUTDOORS INC
- Fiscal year ends
- October 3, 2025
- Latest annual report
- 10-K Β· Dec 12, 2025
- Accession Β· CIK
- 0001140361-25-045348
0000788329
Revenue and margins
Johnson Outdoors Inc had $592M of revenue in fiscal 2025, down 0.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $40.2M in fiscal 2025, 6.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Johnson Outdoors Inc returned $13.6M to shareholders in fiscal 2025, 34% of free cash flow. The diluted share count rose 0.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Johnson Outdoors Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $240M | $130M | $139M | $162M | $176M |
| Debt incl. finance leases | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net debt / EBITDA | β1.9x | β1.6x | β4.9x | β | β39.8x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 767.5x | 433.4x | 77.2x | β286.3x | β72.3x |
| Current ratio | 3.6x | 4.2x | 4.4x | 4.7x | 3.9x |
| Quick ratio | 2.4x | 2.0x | 1.9x | 2.4x | 2.3x |
| Total assets | $674M | $680M | $682M | $635M | $604M |
| Total liabilities | $216M | $192M | $182M | $172M | $186M |
| Shareholders' equity | $459M | $488M | $500M | $463M | $418M |
| Net debt (β = net cash) | β$240M | β$130M | β$139M | β$162M | β$176M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 6 / 9 | 6 / 9 | 4 / 9 | 5 / 9 | 4 / 9 | 2 / 9 | 5 / 9 | 3 / 9 | 4 / 9 |
| Accruals ratio | β9.6% | β3.4% | β6.1% | 1.3% | β1.3% | 4.1% | 15.7% | β3.3% | β10.3% | β14.6% |
| Altman Z'' | 6.88 | 7.62 | 8.45 | 9.41 | 8.41 | 8.57 | 8.78 | 8.37 | 7.76 | 7.23 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $434M | $491M | $544M | $562M | $594M | $752M | $743M | $664M | $593M | $592M |
| Gross profit | $176M | $211M | $242M | $250M | $265M | $334M | $271M | $244M | $201M | $208M |
| Research and development | $18.4M | $19.2M | $20.4M | $21.9M | $24.6M | $25.7M | $27.7M | $31.4M | $31.1M | $32.2M |
| Operating income | $22.9M | $45.6M | $63.0M | $63.8M | $71.1M | $111M | $66.3M | $11.7M | β$43.5M | β$16.2M |
| Interest expense | $0.7M | $0.8M | $0.2M | $0.2M | $0.1M | $0.1M | $0.2M | $0.2M | $0.2M | $0.2M |
| Pretax income | $23.7M | $48.2M | $68.1M | $66.5M | $73.7M | $113M | $58.9M | $25.8M | β$29.9M | β$9.3M |
| Income tax | $10.2M | $13.1M | $27.4M | $15.1M | $18.5M | $29.5M | $14.4M | $6.3M | β$3.3M | $25.0M |
| Net income | $13.5M | $35.2M | $40.7M | $51.4M | $55.2M | $83.4M | $44.5M | $19.5M | β$26.5M | β$34.3M |
| Net income to common | β | β | β | β | β | β | $44.3M | $19.4M | β$26.5M | β$34.3M |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $43.4M | $46.4M | $63.4M | $45.8M | $61.5M | $58.3M | β$62.1M | $41.7M | $41.0M | $56.2M |
| Capital expenditure | $11.7M | $11.6M | $19.2M | $16.8M | $15.6M | $21.4M | $31.7M | $22.7M | $22.0M | $16.0M |
| Free cash flow | $31.7M | $34.7M | $44.2M | $29.1M | $45.9M | $36.9M | β$93.8M | $19.0M | $19.0M | $40.2M |
| Depreciation and amortization | $11.8M | $13.1M | $13.1M | $14.0M | $14.9M | $13.4M | $14.2M | $16.3M | $19.6M | $20.6M |
| Stock-based compensation | $1.8M | $2.0M | $2.3M | $2.3M | $2.7M | $4.2M | $4.1M | $2.4M | $1.3M | $1.5M |
| Acquisitions | $9.2M | $0.0M | $0.0M | β | β | β | β | β | β | β |
| Share buybacks | $1.5M | $0.7M | $0.7M | $0.7M | $0.5M | $0.5M | $0.5M | $0.4M | $0.4M | $0.1M |
| Dividends paid | $3.2M | $3.6M | $4.4M | $5.6M | $6.8M | $8.4M | $12.1M | $12.6M | $13.4M | $13.5M |
| Dividends and buybacks | $4.7M | $4.2M | $5.0M | $6.3M | $7.2M | $8.9M | $12.6M | $13.0M | $13.9M | $13.6M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $87.3M | $110M | $151M | $172M | $212M | $240M | $130M | $139M | $162M | $176M |
| Total debt | $7.4M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $202M | $241M | $286M | $323M | $389M | $491M | $480M | $459M | $429M | $409M |
| Current liabilities | $67.7M | $84.1M | $92.8M | $87.9M | $106M | $138M | $115M | $104M | $90.4M | $105M |
| Inventory | $68.4M | $79.1M | $88.9M | $94.3M | $97.4M | $167M | $249M | $261M | $210M | $171M |
| Property and equipment, net | $49.0M | $48.9M | $55.9M | $59.5M | $63.0M | $71.5M | $89.1M | $94.4M | $96.9M | $93.7M |
| Goodwill | $11.2M | $11.2M | $11.2M | $11.2M | $11.2M | $11.2M | $11.2M | $11.2M | $0.0M | $10.5M |
| Intangible assets | $14.5M | $13.5M | $12.3M | $11.4M | $9.1M | $8.6M | $8.4M | $8.5M | $8.3M | $9.5M |
| Total assets | $310M | $354M | $396M | $436M | $546M | $674M | $680M | $682M | $635M | $604M |
| Total liabilities | $103M | $111M | $117M | $112M | $168M | $216M | $192M | $182M | $172M | $186M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $207M | $243M | $279M | $325M | $378M | $459M | $488M | $500M | $463M | $418M |
| Margins | ||||||||||
| Gross margin | 40.7% | 43.0% | 44.4% | 44.4% | 44.6% | 44.5% | 36.5% | 36.8% | 33.9% | 35.1% |
| Operating margin | 5.3% | 9.3% | 11.6% | 11.3% | 12.0% | 14.8% | 8.9% | 1.8% | β7.3% | β2.7% |
| EBITDA margin | 8.0% | 12.0% | 14.0% | 13.8% | 14.5% | 16.6% | 10.8% | 4.2% | β4.0% | 0.7% |
| Net margin | 3.1% | 7.2% | 7.5% | 9.1% | 9.3% | 11.1% | 6.0% | 2.9% | β4.5% | β5.8% |
| FCF margin | 7.3% | 7.1% | 8.1% | 5.2% | 7.7% | 4.9% | β12.6% | 2.9% | 3.2% | 6.8% |
| Returns | ||||||||||
| Return on capital | 11.7% | 25.1% | 31.9% | 32.4% | 32.1% | 37.7% | 14.0% | 2.5% | β11.4% | β5.3% |
| Return on capital employed | 9.4% | 16.9% | 20.8% | 18.3% | 16.1% | 20.7% | 11.7% | 2.0% | β8.0% | β3.2% |
| Return on equity | 6.5% | 15.6% | 15.6% | 17.0% | 15.7% | 19.9% | 9.4% | 4.0% | β5.5% | β7.8% |
| Return on assets | 4.4% | 10.6% | 10.9% | 12.4% | 11.2% | 13.7% | 6.6% | 2.9% | β4.0% | β5.5% |
| Return on tangible equity | 7.4% | 16.1% | 15.9% | 17.0% | 15.4% | 19.0% | 9.5% | 4.0% | β5.8% | β8.6% |
| Growth | ||||||||||
| Revenue growth | β | 13.1% | 10.9% | 3.3% | 5.7% | 26.5% | β1.1% | β10.7% | β10.7% | β0.1% |
| Net income growth | β | 160.4% | 15.7% | 26.4% | 7.4% | 51.0% | β46.6% | β56.1% | β235.8% | β |
| FCF growth | β | 9.5% | 27.3% | β34.3% | 57.9% | β19.6% | β354.2% | β | β0.4% | 112.1% |
| Share count change | β | 0.7% | 0.8% | 0.3% | 0.4% | 0.6% | 0.3% | 0.4% | 0.3% | 0.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | β2.3x | β1.9x | β2.0x | β2.2x | β2.5x | β1.9x | β1.6x | β4.9x | β | β39.8x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 31.5x | 60.2x | 310.4x | 370.8x | 497.0x | 767.5x | 433.4x | 77.2x | β286.3x | β72.3x |
| Current ratio | 3.0x | 2.9x | 3.1x | 3.7x | 3.7x | 3.6x | 4.2x | 4.4x | 4.7x | 3.9x |
| Quick ratio | 2.0x | 1.9x | 2.1x | 2.6x | 2.8x | 2.4x | 2.0x | 1.9x | 2.4x | 2.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.7% | 2.4% | 3.5% | 3.0% | 2.6% | 2.8% | 4.3% | 3.4% | 3.7% | 2.7% |
| Stock comp / revenue | 0.4% | 0.4% | 0.4% | 0.4% | 0.5% | 0.6% | 0.6% | 0.4% | 0.2% | 0.3% |
| Payouts / FCF | 14.7% | 12.2% | 11.4% | 21.6% | 15.8% | 24.1% | β | 68.2% | 73.1% | 33.9% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 6.0 | 6.0 | 4.0 | 5.0 | 4.0 | 2.0 | 5.0 | 3.0 | 4.0 |
| Altman Z'' | 6.9 | 7.6 | 8.4 | 9.4 | 8.4 | 8.6 | 8.8 | 8.4 | 7.8 | 7.2 |
| Accruals ratio | β9.6% | β3.4% | β6.1% | 1.3% | β1.3% | 4.1% | 15.7% | β3.3% | β10.3% | β14.6% |
Source: SEC EDGAR XBRL filings (CIK 0000788329). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.